Ketorolac for Pericarditis
Ketorolac can be used as an NSAID option for acute pericarditis, but aspirin or ibuprofen are preferred first-line choices due to more extensive evidence and favorable dosing profiles; ketorolac is FDA-approved only for short-term use (≤5 days) which is insufficient for typical pericarditis treatment duration of 1-2 weeks. 1
First-Line Treatment Approach
Aspirin or NSAIDs combined with colchicine are the mainstay of therapy for acute pericarditis. 2, 3
Preferred NSAID Options
Aspirin 750-1000 mg every 8 hours is the preferred choice, particularly in patients with:
Ibuprofen 600 mg every 8 hours is an alternative first-line option 2, 3
Ketorolac-Specific Considerations
Ketorolac has relative evidence for pericarditis treatment but faces significant practical limitations: 4
- FDA approval restricts use to ≤5 days maximum (combined IV/IM and oral routes) 1
- This duration is inadequate for typical pericarditis treatment, which requires 1-2 weeks of therapy 2, 3
- Available as IV/IM formulation, useful for patients unable to take oral medications 4
- Must be mindful of maximum dosing limits 4
Mandatory Colchicine Addition
Colchicine must be added to NSAID therapy as first-line treatment to improve response and prevent recurrences (reduces recurrence from 37.5% to 16.7%). 2, 3, 5
- Weight-adjusted dosing: 6, 3
- 0.5 mg once daily if <70 kg
- 0.5 mg twice daily if ≥70 kg
- Duration: 3 months 2, 6, 3
- Tapering not mandatory but may be considered 2
Treatment Monitoring and Duration
- Continue NSAIDs until complete symptom resolution AND CRP normalization 2, 3
- Gastroprotection is mandatory with all NSAIDs 2, 3
- Typical treatment duration: 1-2 weeks for uncomplicated cases 2, 3
- Begin tapering only after symptoms resolve and CRP normalizes 3
Activity Restriction
- Restrict physical activity beyond ordinary sedentary life until symptom resolution and CRP normalization 2
- Athletes require minimum 3-month restriction from competitive sports after symptom onset 2, 3
- Non-athletes may resume activity sooner once symptoms resolve 2
Second-Line Treatment (If NSAIDs Fail)
Corticosteroids should be considered only after NSAID/colchicine failure or contraindications, as they risk promoting chronicity and recurrence. 2, 3
- Low to moderate doses: prednisone 0.2-0.5 mg/kg/day (NOT 1.0 mg/kg/day) 2, 3
- Maintain initial dose until symptom resolution and CRP normalization, then taper slowly 2
- Corticosteroids are NOT first-line therapy 3, 5
Critical Pitfalls to Avoid
- Do not use ketorolac as monotherapy beyond 5 days - this violates FDA labeling and is insufficient for pericarditis 1
- Never start NSAIDs without colchicine - inadequate first-episode treatment is the most common cause of recurrence 3
- Avoid premature tapering - only taper when symptoms are absent AND CRP is normal 3
- Do not use corticosteroids first-line - they increase recurrence risk (50% after first recurrence vs. 15-30% without) 3, 5
Clinical Algorithm
- Diagnose pericarditis (≥2 of: chest pain, ECG changes, pericardial effusion, friction rub) 5
- Start aspirin 750-1000 mg q8h OR ibuprofen 600 mg q8h (NOT ketorolac due to 5-day limit) 2, 3
- Add colchicine (weight-adjusted) for 3 months 6, 3
- Provide gastroprotection 2, 3
- Monitor CRP to guide treatment duration 3
- Taper NSAIDs over 1-2 weeks once symptoms resolve and CRP normalizes 2, 3
- If no response: Consider low-dose corticosteroids 3